Clinical, morphological and molecular genetic prognostic factors for survival rates in non-muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Clinical, morphological and molecular genetic prognostic factors for survival rates in non-muscle-invasive bladder cancer

Published:2018 Issue:1 Volume:7 Page:49
ISSN:2305-218X
Container-title:Onkologiya. Zhurnal imeni P.A.Gertsena
language:en
Short-container-title:Onkol. Z. im. P.A. Gercena

Author:

Kaprin A. D.,Apolikhin O. I.,Alekseev B. Ya.,Sivkov A. V.,Efremov G. D.,Roshchin D. A.,Mikhailenko D. S.,Kachmazov A. A.,Perepechin D. V.,Deryagina D. M.

Publisher

Media Sphere Publishing Group

Subject

General Medicine

Reference52 articles.

1. Global cancer statistics, 2012

2. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

3. Comparison of expected treatment outcomes, obtained using risk models and international guidelines, with observed treatment outcomes in a Dutch cohort of patients with non-muscle-invasive bladder cancer treated with intravesical chemotherapy

4. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use

5. Wang QY, Zhao Y, Zhang R. The role of mutations and overexpression of the fibroblast growth factor receptor-3 in bladder cancer. Minerva Med. 2015;106(6):333-337.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular genetic subtypes of bladder cancer;Urology Herald;2023-10-05

2. Results of using domestic fluorescent video system in the diagnosis and treatment of non-muscle-invasive bladder cancer;Onkologiya. Zhurnal imeni P.A.Gertsena;2020